Zydus Life Science Quarterly Results for Trading Insights
ZYDUSLIFE • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1,239 Cr
QSept 2025
Zydus Life Science Quarterly Results Key Highlights
- Revenue of ₹6,147 Cr in Sept 2025 (-3.5% vs Mar 2025, +18.6% vs Sept 2024)
- Net Profit of ₹1,239 Cr in Sept 2025 (-0.4% vs Mar 2025, +34.7% vs Sept 2024)
- EBITDA of ₹2,005 Cr in Sept 2025 (+14.6% vs Mar 2025)
- Operating Margin of 31.0% in Sept 2025 (+4.0pp vs Mar 2025)
- Earnings Per Share of ₹12.51 in Sept 2025 (+7.5% vs Mar 2025)
Zydus Life Science Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 6,147 | 6,371 | 6,622 | 5,182 | 5,526 | -3.5% | 18.6% |
| Net Profit (₹ Cr) | 1,239 | 1,244 | 1,521 | 920 | 1,246 | - | - |
| EBITDA (₹ Cr) | 2,005 | 1,749 | 2,137 | 1,407 | 1,623 | - | - |
| EPS (₹) | 12.51 | 11.64 | 14.58 | 9.06 | 11.69 | - | - |
| Operating Margin (%) | 31.0% | 27.0% | 31.0% | 26.0% | 27.0% | - | - |
Zydus Life Science Share Price Trend Around Quarterly Results
Visualize Zydus Life Science's 1-year price movement across quarterly results — ideal for logging trades in Zydus Life Science share price
chart using Tickjournal. All values in ₹.
Related Pages for Zydus Life Science
Additional stock information and data for ZYDUSLIFE
Revenue Trend (₹ Cr)
Sept 2024
5,182
Jun 2025
6,622
Mar 2025
6,371
Sept 2025
6,147
Net Profit Trend (₹ Cr)
Sept 2024
920
Jun 2025
1,521
Mar 2025
1,244
Sept 2025
1,239
Operating Margin Trend (%)
Sept 2024
26.0%
Jun 2025
31.0%
Mar 2025
27.0%
Sept 2025
31.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Zydus Life Science quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹412,613.60 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹169,700.80 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹129,171.09 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,570.84 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores